KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oscar Health (OSCR) Enterprise Value (2020 - 2025)

Oscar Health (OSCR) has disclosed Enterprise Value for 6 consecutive years, with -$4.0 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Enterprise Value fell 85.57% year-over-year to -$4.0 billion, compared with a TTM value of -$4.0 billion through Dec 2025, down 85.57%, and an annual FY2025 reading of -$4.0 billion, down 85.57% over the prior year.
  • Enterprise Value was -$4.0 billion for Q4 2025 at Oscar Health, down from -$3.0 billion in the prior quarter.
  • Across five years, Enterprise Value topped out at -$1.7 billion in Q3 2021 and bottomed at -$4.0 billion in Q4 2025.
  • Average Enterprise Value over 5 years is -$2.8 billion, with a median of -$2.8 billion recorded in 2022.
  • The sharpest move saw Enterprise Value plummeted 451.2% in 2021, then soared 30.09% in 2024.
  • Year by year, Enterprise Value stood at -$1.7 billion in 2021, then plummeted by 75.22% to -$3.0 billion in 2022, then grew by 13.4% to -$2.6 billion in 2023, then increased by 16.0% to -$2.1 billion in 2024, then crashed by 85.57% to -$4.0 billion in 2025.
  • Business Quant data shows Enterprise Value for OSCR at -$4.0 billion in Q4 2025, -$3.0 billion in Q3 2025, and -$3.5 billion in Q2 2025.